1. Home
  2. NWTG vs ACXP Comparison

NWTG vs ACXP Comparison

Compare NWTG & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newton Golf Company Inc.

NWTG

Newton Golf Company Inc.

HOLD

Current Price

$0.92

Market Cap

5.3M

ML Signal

HOLD

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$1.14

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWTG
ACXP
Founded
2018
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
6.2M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
NWTG
ACXP
Price
$0.92
$1.14
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
$4.50
★ $17.00
AVG Volume (30 Days)
★ 219.0K
77.5K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 99.09
N/A
EPS
★ N/A
N/A
Revenue
★ $8,135,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$104.02
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 136.14
N/A
52 Week Low
$0.70
$1.07
52 Week High
$1.94
$7.54

Technical Indicators

Market Signals
Indicator
NWTG
ACXP
Relative Strength Index (RSI) 42.26 34.05
Support Level $0.78 N/A
Resistance Level $1.17 $1.75
Average True Range (ATR) 0.15 0.06
MACD -0.02 -0.01
Stochastic Oscillator 24.55 24.48

Price Performance

Historical Comparison
NWTG
ACXP

About NWTG Newton Golf Company Inc.

Newton Golf Co Inc is a technology-forward golf company engaged in designing, manufacturing, and selling performance golf equipment, including premium golf shafts and putters, and focuses on developing technology-driven golf products intended to enhance player performance. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

Share on Social Networks: